ArticleEuropean journal of pediatrics2016

Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.

Ryszard Grenda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.